Cargando…

Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse

BACKGROUND: Immunoglobulin G4-related disease (IgG4-RD) promptly responds to glucocorticoids but relapses in a considerable fraction of patients. Reliable biomarkers of flare are currently lacking because the pathophysiology of IgG4-RD remains largely elusive. In the present work, we aimed to identi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanzillotta, Marco, Della-Torre, Emanuel, Milani, Raffaella, Bozzolo, Enrica, Bozzalla-Cassione, Emanuele, Rovati, Lucrezia, Arcidiacono, Paolo Giorgio, Partelli, Stefano, Falconi, Massimo, Ciceri, Fabio, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235221/ https://www.ncbi.nlm.nih.gov/pubmed/30285841 http://dx.doi.org/10.1186/s13075-018-1718-5

Ejemplares similares

Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature
por: Della-Torre, Emanuel, et al.
Publicado: (2016)

Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply
por: Della-Torre, Emanuel, et al.
Publicado: (2022)

Serum IgG4 level predicts COVID-19 related mortality
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
por: Bozzalla Cassione, Emanuele, et al.
Publicado: (2022)

Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study
por: Tacelli, Matteo, et al.
Publicado: (2022)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2020)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis
por: Ramirez, Giuseppe A., et al.
Publicado: (2022)

IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients
por: Rampi, Andrea, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
por: Ramirez, Giuseppe A., et al.
Publicado: (2020)

Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis
por: De Stefano, Ludovico, et al.
Publicado: (2023)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Treating COVID-19 with colchicine in community healthcare setting
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Insights Into the Concept of Rheumatoid Arthritis Flare
por: Bozzalla-Cassione, Emanuele, et al.
Publicado: (2022)

Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis
por: Bartoletti, Alice, et al.
Publicado: (2023)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Remissions and Relapses in Insular Sclerosis
Publicado: (1904)

Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
por: Rossi, Gemma, et al.
Publicado: (2022)

Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study
por: Shirakashi, Mirei, et al.
Publicado: (2018)

Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients
por: Wang, Liwen, et al.
Publicado: (2018)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Partial remission, residual symptoms, and relapse in depression
por: Paykel, E.S.
Publicado: (2008)

Diabetes remission and relapse after metabolic surgery
por: Chen, Xiaoping, et al.
Publicado: (2018)

Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature
por: Paolino, Giovanni, et al.
Publicado: (2023)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
por: Gottlieb, S., et al.
Publicado: (2014)

Unusual Relapse of Chronic Lymphocytic Leukemia After Remission
por: Rizvi, Wajeeha, et al.
Publicado: (2018)

Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study
por: Moroni, Luca, et al.
Publicado: (2022)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

Exploiting antitumor immunity to overcome relapse and improve remission duration
por: Chen, Lei L., et al.
Publicado: (2011)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Is IgG galactosylation the relevant factor for pregnancy-induced remission of rheumatoid arthritis?
por: Förger, Frauke, et al.
Publicado: (2010)

Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy
por: Furuto, Yoshitaka, et al.
Publicado: (2023)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5tq5c93bskg4tmv8d1g0p8t0j0